Efficacy and safety of soluble guanylate cyclase stimulators or activators for chronic kidney disease: a systematic review and meta-analysis
BackgroundChronic Kidney Disease (CKD) poses a major global health burden, leading to serious complications and death. The nitric oxide (NO)-soluble guanylate cyclase (sGC)-cyclic guanosine monophosphate (cGMP) signaling axis regulates various kidney functions. sGC stimulators (sGCs) and activators...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-03-01
|
| Col·lecció: | Frontiers in Medicine |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fmed.2026.1778037/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|